Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Free Cash Flow: 2016-2024

Historic Free Cash Flow for Krystal Biotech (KRYS) over the last 9 years, with Dec 2024 value amounting to $114.9 million.

  • Krystal Biotech's Free Cash Flow fell 35.81% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.2 million, marking a year-over-year increase of 205.73%. This contributed to the annual value of $114.9 million for FY2024, which is 214.23% up from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Free Cash Flow is $114.9 million, which was up 214.23% from -$100.6 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Free Cash Flow ranged from a high of $114.9 million in FY2024 and a low of -$153.5 million during FY2022.
  • For the 3-year period, Krystal Biotech's Free Cash Flow averaged around -$46.4 million, with its median value being -$100.6 million (2023).
  • In the last 5 years, Krystal Biotech's Free Cash Flow plummeted by 184.11% in 2021 and then soared by 214.23% in 2024.
  • Over the past 5 years, Krystal Biotech's Free Cash Flow (Yearly) stood at -$40.9 million in 2020, then slumped by 184.11% to -$116.3 million in 2021, then crashed by 32.06% to -$153.5 million in 2022, then soared by 34.48% to -$100.6 million in 2023, then soared by 214.23% to $114.9 million in 2024.